Literature DB >> 12459334

No false start for novel pseudotyped vectors.

David Avram Sanders1.   

Abstract

Pseudotyped vectors can be used to introduce genes into cells or to study the entry process of the virus from which the outer shell of the recombinant virus is derived. Recently, several novel pseudotyped retroviruses and lentiviruses have been constructed. Virus vectors pseudotyped with an alphavirus glycoprotein hold special promise. The increasing diversity of the available pseudotyped vectors offers expanded opportunities for gene transfer to specific cells.

Mesh：

Substances：

Year:  2002        PMID： 12459334     DOI： 10.1016/s0958-1669(02)00374-9

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN： 0958-1669            Impact factor:   9.740


  21 in total

1.  Efficient functional pseudotyping of oncoretroviral and lentiviral vectors by Venezuelan equine encephalitis virus envelope proteins.

Authors:  Andrey A Kolokoltsov; Scott C Weaver; Robert A Davey
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  A dual-targeted lentiviral vector homing in on prostate bone metastases.

Authors:  Yufang Hu; David Stout; Lily Wu
Journal:  Mol Ther       Date:  2007-11       Impact factor: 11.454

3.  Phylogenetic and biological analysis of a laboratory-generated gammaretrovirus xenotropic murine leukemia virus-related virus (XMRV).

Authors:  Xiaochu Ma; Shiying Zhou; Meili Wei; Yanxia Chen; Jiaqiang Li; Weiliang Xiong; Shibo Jiang; Chungen Pan
Journal:  Virus Genes       Date:  2012-06-27       Impact factor: 2.332

Review 4.  Strategies and methods for the detection and identification of viral vectors.

Authors:  Thorsten Stellberger; Nina Koehler; Anna Dinkelmeier; Johannes Draxler; Maren Haase; Jessica Hellinckx; Melanie Pavlovic; Ulrich Busch; Armin Baiker
Journal:  Virus Genes       Date:  2017-07-19       Impact factor: 2.332

5.  Identification of novel cellular targets for therapeutic intervention against Ebola virus infection by siRNA screening.

Authors:  Andrey A Kolokoltsov; Mohammad F Saeed; Alexander N Freiberg; Michael R Holbrook; Robert A Davey
Journal:  Drug Dev Res       Date:  2009-06-01       Impact factor: 4.360

6.  Adaptive evolution of a tagged chimeric gammaretrovirus: identification of novel cis-acting elements that modulate splicing.

Authors:  Christopher R Logg; Brian T Baranick; Nathan A Lemp; Noriyuki Kasahara
Journal:  J Mol Biol       Date:  2007-04-19       Impact factor: 5.469

7.  pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN.

Authors:  Zhi-Yong Yang; Yue Huang; Lakshmanan Ganesh; Kwanyee Leung; Wing-Pui Kong; Owen Schwartz; Kanta Subbarao; Gary J Nabel
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

8.  Human immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virus.

Authors:  Christoph A Kahl; Jon Marsh; Joanne Fyffe; David A Sanders; Kenneth Cornetta
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Mannosyl glycodendritic structure inhibits DC-SIGN-mediated Ebola virus infection in cis and in trans.

Authors:  Fátima Lasala; Eva Arce; Joaquín R Otero; Javier Rojo; Rafael Delgado
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

10.  Trimer Enhancement Mutation Effects on HIV-1 Matrix Protein Binding Activities.

Authors:  Ayna Alfadhli; Andrew Mack; Christopher Ritchie; Isabel Cylinder; Logan Harper; Philip R Tedbury; Eric O Freed; Eric Barklis
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.